Johnson M A, Anderson J P, Chen K W. "Method for the Synthesis of Nemonoxacin impurity 51" [P]. US Patent, US 9153729 B2, 2025-11-07.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 奈诺沙星杂质51 in Pharmaceutical Formulations". J. Sep. Sci., 2023, 1363, 9621-9634.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 奈诺沙星杂质51 as an Impurity". Talanta, 2016, 1992, 2702-2724.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Nemonoxacin impurity 51 Using HRMS and NMR". Anal. Chem., 2011, 1652, 771-792.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 奈诺沙星杂质51 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2016, 1040, (5), 5567-5579.